FV Pharma International (FVPI) 10-Q 20 Jun 14 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Apr. 30, 2014	Jun. 19, 2014
Document And Entity Information	'	'
Entity Registrant Name	'ALPHALA CORP.	'
Entity Central Index Key	'0001565220	'
Document Type	'10-Q	'
Document Period End Date	30-Apr-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--01-31	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	250,800,000
Document Fiscal Period Focus	'Q1	'
Document Fiscal Year Focus	'2015	'

Condensed_Balance_Sheets_Unaud

Condensed Balance Sheets (Unaudited) (USD $)	Apr. 30, 2014	Jan. 31, 2014
Current Assets	'	'
Cash	$3,859	$3,919
Prepaid expenses	333	2,333
Income taxes receivable	264	264
Total current assets	4,456	6,516
Total assets	4,456	6,516
Current Liabilities	'	'
Due to related party	3,723	'
Accounts payable	11,118	'
Total current liabilities	14,841	0
Total liabilities	14,841	0
Stockholders' Equity (Deficit)	'	'
Common stock, $0.001 par value, 750,000,000 shares authorized; 250,800,000 shares issued and outstanding	250,800	250,800
Additional paid-in-capital	-215,400	-215,400
Deficit accumulated during development stage	-45,785	-28,884
Total stockholders' equity (deficit)	-10,385	6,516
Total liabilities and stockholders' equity (deficit)	$4,456	$6,516

Condensed_Balance_Sheets_Unaud1

Condensed Balance Sheets (Unaudited) (Parenthetical) (USD $)	Apr. 30, 2014	Apr. 14, 2014	Jan. 31, 2014
Statement of Financial Position [Abstract]	'	'	'
Common stock, par value	$0.00	'	$0.00
Common Stock, shares authorized	750,000,000	29	750,000,000
Common Stock, shares issued	250,800,000	'	250,800,000
Common Stock, shares outstanding	250,800,000	'	250,800,000

Condensed_Statements_of_Operat

Condensed Statements of Operations (Unaudited) (USD $)	3 Months Ended				27 Months Ended
	Apr. 30, 2014		Apr. 30, 2013		Apr. 30, 2014
Income Statement [Abstract]	'		'		'
Revenues	'		'		$2,475
Operating expenses	'		'		'
General and administrative	16,901		7,249		48,260
Total operating expenses	16,901		7,249		48,260
Net loss	($16,901)		($7,249)		($45,785)
Loss per share - Basic and Diluted	$0	[1]	$0	[1]	'
Weighted Average Shares-Basic and Diluted	250,800,000		250,800,000		'
[1]	denotes a loss of less than $(0.01) per share.

Condensed_Statement_of_Changes

Condensed Statement of Changes in Stockholders' Equity (Deficit) (Unaudited) (USD $)	Common Stock [Member]	Additional Paid-In Capital [Member]	Deficit Accumulated During Development Stage [Member]	Total
Balance at Feb. 09, 2012	'	'	'	'
Balance, Shares at Feb. 09, 2012	'	'	'	'
Common shares issued for cash at $0.001 per share	180,000	-174,000	'	6,000
Common shares issued for cash at $0.001 per share, shares	180,000,000	'	'	'
Common shares issued for cash at $0.01 per share	70,800	-47,200	'	23,600
Common shares issued for cash at $0.01 per share, shares	70,800,000	'	'	'
Net income (loss)	'	'	1,408	1,408
Balance at Jan. 31, 2013	250,800	-221,200	1,408	31,008
Balance, shares at Jan. 31, 2013	250,800,000	'	'	'
Forgiveness of loan from shareholder	'	5,800	'	5,800
Net income (loss)	'	'	-30,292	-30,292
Balance at Jan. 31, 2014	250,800	-215,400	-28,884	6,516
Balance, shares at Jan. 31, 2014	250,800,000	'	'	'
Forgiveness of loan from shareholder	'	'	'	'
Net income (loss)	'	'	-16,901	-16,901
Balance at Apr. 30, 2014	$250,800	($215,400)	($45,785)	($10,385)
Balance, shares at Apr. 30, 2014	250,800,000	'	'	'

Condensed_Statement_of_Stockho

Condensed Statement of Stockholders' Equity (Deficit) (Unaudited) (Parenthetical) (USD $)	12 Months Ended
	Jan. 31, 2013
Statement of Stockholders' Equity [Abstract]	'
Stock issued for cash price per share	$0.00
Stock issued for cash price per share	$0.01

Condensed_Statements_of_Cash_F

Condensed Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended		27 Months Ended
	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014
Operating Activities	'	'	'
Net loss	($16,901)	($7,249)	($45,785)
Changes in non-cash working capital items:	'	'	'
Prepaid expenses	2,000	'	-333
Income tax receivable	'	'	-264
Due to related party	3,723	'	3,723
Accounts payable	11,118	'	11,118
Income tax payable	'	-264	'
Net cash provided by (used in) operating activities	-60	-7,513	-31,541
Investing Activities	'	'	'
Net cash provided by (used in) investing activities	0	0	0
Financing Activities	'	'	'
Proceeds from issuance of common stock	'	'	29,600
Proceeds from loan from shareholder	'	'	5,800
Net cash provided by financing activities	0	0	35,400
Change in cash	-60	-7,513	3,859
Cash at beginning of the period	3,919	31,560	'
Cash at end of the period	3,859	24,047	3,859
Cash paid for:	'	'	'
Interest	'	'	'
Taxes	'	'	264
Non-Cash Financing activities	'	'	'
Forgiveness of related party loan	'	'	$5,800

Organization_and_Business_Oper

Organization and Business Operations	3 Months Ended
	Apr. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Organization and Business Operations	'
	NOTE 1 – ORGANIZATION AND BUSINESS OPERATIONS
	Organization and Description of Business
	ALPHALA CORP. (the “Company”) was incorporated under the laws of the State of Nevada on February 9, 2012 (Inception) and plans to commence operation in the distribution of teeth whitening products. The Company is in the development stage as defined under Financial Accounting Standards Board Accounting Standards Codification (“ASC”) 915-205 “Development-Stage Entities”. For the period from Inception on February 9, 2012 through April 30, 2014 the Company has accumulated losses of $45,785.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2014
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Basis of Presentation
	The accompanying unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles as promulgated in the United States of America (“U.S. GAAP”) and the instructions from Regulation S-X and do not include all of the information and disclosures required by generally accepted accounting principles for complete financial statements. All adjustments which are, in the opinion of management, necessary for a fair presentation of the results of operations for the interim period(s), and to make the financial statements not misleading, have been made and are of a recurring nature unless otherwise disclosed herein. The results of operations for such interim period(s) are not necessarily indicative of operations for a full year.
	Cash and Cash Equivalents
	For purposes of the statement of cash flows, the Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents.
	The Company’s bank accounts are deposited in insured institutions. The funds are insured up to $250,000. At April 30, 2014 and January 31, 2014, the Company’s bank deposits did not exceed the insured amounts.
	Basic and Diluted Income (Loss) Per Share
	The Company computes loss per share in accordance with ASC 260, “Earnings per Share”, which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted loss per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. No potentially dilutive debt or equity instruments were issued of outstanding during the three month periods ended April 30, 2014 or 2013.
	Income Taxes
	The Company accounts for income taxes pursuant to ASC 740, “Income Taxes”. Under ASC 740, deferred income taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The provision for income taxes represents the tax expense for the period, if any, and the change during the period in deferred tax assets and liabilities. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
	ASC 740 also provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax positions. Under ASC 740, the impact of an uncertain tax position on the income tax return may only be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. At April 30, 2014 and January 31, 2014, there were no unrecognized tax benefits.
	Revenue Recognition
	The Company recognizes revenue in accordance with ASC 605, “Revenue Recognition”. ASC 605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectibility is reasonably assured. Determination of criteria (3) and (4) are based on management’s judgments regarding the fixed nature of the selling prices of the products delivered and the collectibility of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required.
	Advertising Costs
	The Company’s policy regarding advertising is to expense advertising when incurred. The Company incurred advertising expense of $0 during the three month periods ended April 30, 2014 and 2013.
	Recent Accounting Pronouncements
	Management does not believe that any recently issued, but not yet effective, accounting standards, if adopted, will have a material effect on the Company’s condensed financial statements.
	Fair Value of Financial Instruments
	ASC 820, “Fair Value Measurements and Disclosures”, establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market.
	These tiers include:
	Level 1: defined as observable inputs such as quoted prices in active markets;
	Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and
	Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.
	The carrying amounts of financial assets and liabilities, such as cash, prepaid expenses, income taxes receivable, accounts payable and due to related party approximate their fair values because of the short maturity of these instruments.
	Use of Estimates
	The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Going_Concern

Going Concern	3 Months Ended
	Apr. 30, 2014
Going Concern	'
Going Concern	'
	NOTE 3 – GOING CONCERN
	The accompanying condensed unaudited financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred a loss since Inception (February 9, 2012) resulting in an accumulated deficit of $45,785 as of April 30, 2014, and further losses are anticipated in the development of its business. Accordingly, there is substantial doubt about the Company’s ability to continue as a going concern.
	The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/ or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due.

Common_Stock

Common Stock	3 Months Ended
	Apr. 30, 2014
Equity [Abstract]	'
Common stock	'
	NOTE 4 – COMMON STOCK
	Common Stock
	The Company has 750,000,000 shares of common stock authorized with a par value of $0.001 per share.
	On October 22, 2012, the Company issued 180,000,000 shares of its common stock for total proceeds of $6,000.
	During the period from October 29, 2012 to December 4, 2012, the Company issued 70,800,000 shares of its common stock for total proceeds of $23,600.
	On April 11, 2014, the holders of a majority of the Company’s issued and outstanding common stock approved an increase in its authorized capital from 75,000,000 shares of common stock, par value $0.001, to 750,000,000 shares of common stock, par value $0.001 (the “Authorized Capital Increase”). The purpose of the Authorized Capital Increase was to reorganize the Company’s capital structure in connection with the stock dividend described below. The Company formally effected the Authorized Capital Increase on April 11, 2014 by filing a Certificate of Amendment with the Nevada Secretary of State.
	On April 14, 2014, the Company’s sole director approved a stock dividend of 29 authorized but unissued shares of common stock on each one (1) pre-dividend issued and outstanding share of the Company’s common stock. On May 1, 2014, the Company received approval from the Financial Industry Regulatory Authority (FINRA) to effect the stock dividend by way of a forward split, and on the same date, the Company’s shareholders of record on April 25, 2014 received the dividend. As a result of the stock dividend, the Company’s issued and outstanding common stock increased from 8,360,000 (pre-dividend) shares to 250,800,000 (post-dividend) shares. All references to common stock have been reflected retroactively.
	As at April 30, 2014 and January 31, 2014, 250,800,000 shares of common stock were issued and outstanding.
	Additional paid in Capital
	From February 9, 2012 (Inception) through January 31, 2014, the Company’s former sole director and principal shareholder loaned the Company a total of $5,800 to pay for incorporation costs and operating expenses. The loan was non-interest bearing, due upon demand and unsecured. Effective January 31, 2014, the Company’s former sole director and principal shareholder forgave repayment of the $5,800 outstanding loan balance which was credited to additional paid in capital at that time.

Related_Party_Transactions

Related Party Transactions	3 Months Ended
	Apr. 30, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	NOTE 5 – RELATED PARTY TRANSACTIONS
	In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by shareholders. Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are considered temporary in nature and have not been formalized by a promissory note.
	From February 9, 2012 (inception) through January 31, 2014, the Company’s former sole director and principal shareholder loaned the Company a total of $5,800 to pay for incorporation costs and operating expenses. The loan was non-interest bearing, due upon demand and unsecured. Effective January 31, 2014, the Company’s former sole director and principal shareholder forgave repayment of the $5,800 outstanding loan balance which was credited to additional paid in capital at that time.
	As at April 30, 2014, the Company owed $3,723 to its sole director and principal shareholder for expense reimbursements. The loan is non-interest bearing, unsecured and has no specific repayment terms.

Income_Taxes

Income Taxes	3 Months Ended
	Apr. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	NOTE 6 – INCOME TAXES
	During the period from February 9, 2012 (Inception) through January 31, 2013, the Company recognized a taxable profit of $1,760, accrued a tax liability of $352 and paid $264 tax in respect of this liability during the twelve months ended January 31, 2014.
	During the twelve months ended January 31, 2014, the Company incurred taxable losses of $30,644. $1,760 of these losses can be carried back to offset the $1,760 taxable profits arising in the period from February 9, 2012 (Inception) through January 31, 2013 and accordingly the Company is entitled to a refund of the $264 of tax paid in respect of this period and to recognize a full credit for the $352 tax liability provided for in the prior period. The remaining balance of $28,884 unrelieved tax losses are potentially available to offset taxable profits the Company may generate in the future.
	During the three months ended April 30, 2014 the Company incurred further tax losses of $16,901 increasing the total available tax losses potentially available to offset taxable profits the Company may generate in the future to $45,785. The net operating loss carry forward will expire between 2033 and 2034. This carry forward may be limited upon the consummation of a business combination under IRC Section 381.
	When it is more likely than not that a tax asset cannot be realized through future income, the Company must record an allowance against any future potential future tax benefit. The Company provided a full valuation allowance against the net deferred tax asset, consisting of net operating loss carry forwards, because management has determined that it is more likely than not that it will not earn income sufficient to realize the deferred tax assets during the carry forward periods.
	The Company has not taken a tax position that, if challenged, would have a material effect on the financial statements for the three month periods ended April 30, 2014 and 2013 as defined under ASC 740, “Accounting for Income Taxes”. The Company did not recognize any adjustment to the liability for uncertain tax position and therefore did not record any adjustment to the beginning balance of the accumulated deficit on the balance sheet.

Subsequent_Event

Subsequent Event	3 Months Ended
	Apr. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Event	'
	NOTE 7 – SUBSEQUENT EVENT
	On June 10, 2014, the Company entered into a non-binding letter of intent with FV Pharma Inc., a private Ontario, Canada corporation (“FV Pharma”), and all the holders of the Class B non-voting shares of FV Pharma (the “Shares”), pursuant to which the Company agreed to acquire 100% of the Shares from such holders in exchange for the allotment and issuance of 150,000,000 restricted shares of the Company’s common stock (the “Transaction”). The Transaction is expected to take the form of a share exchange with the result that FV Pharma will become a partially owned subsidiary of the Company, and is subject to certain closing conditions. FV Pharma has applied to Health Canada to become a licensed commercial producer of marijuana under the Government of Canada’s new Marihuana for Medical Purposes Regulations (the “MMPR”).
	The Company has evaluated all other subsequent events through the date of issuance of the accompanying condensed unaudited financial statements on June 19, 2014 and other than as disclosed above, the Company did not have any material recognizable subsequent events.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2014
Accounting Policies [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	The accompanying unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles as promulgated in the United States of America (“U.S. GAAP”) and the instructions from Regulation S-X and do not include all of the information and disclosures required by generally accepted accounting principles for complete financial statements. All adjustments which are, in the opinion of management, necessary for a fair presentation of the results of operations for the interim period(s), and to make the financial statements not misleading, have been made and are of a recurring nature unless otherwise disclosed herein. The results of operations for such interim period(s) are not necessarily indicative of operations for a full year.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	For purposes of the statement of cash flows, the Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents.
	The Company’s bank accounts are deposited in insured institutions. The funds are insured up to $250,000. At April 30, 2014 and January 31, 2014, the Company’s bank deposits did not exceed the insured amounts.
Basic and Diluted Income (Loss) Per Share	'
	Basic and Diluted Income (Loss) Per Share
	The Company computes loss per share in accordance with ASC 260, “Earnings per Share”, which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted loss per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. No potentially dilutive debt or equity instruments were issued of outstanding during the three month periods ended April 30, 2014 or 2013.
Income Taxes	'
	Income Taxes
	The Company accounts for income taxes pursuant to ASC 740, “Income Taxes”. Under ASC 740, deferred income taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The provision for income taxes represents the tax expense for the period, if any, and the change during the period in deferred tax assets and liabilities. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
	ASC 740 also provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax positions. Under ASC 740, the impact of an uncertain tax position on the income tax return may only be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. At April 30, 2014 and January 31, 2014, there were no unrecognized tax benefits.
Revenue Recognition	'
	Revenue Recognition
	The Company recognizes revenue in accordance with ASC 605, “Revenue Recognition”. ASC 605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectibility is reasonably assured. Determination of criteria (3) and (4) are based on management’s judgments regarding the fixed nature of the selling prices of the products delivered and the collectibility of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required.
Advertising Costs	'
	Advertising Costs
	The Company’s policy regarding advertising is to expense advertising when incurred. The Company incurred advertising expense of $0 during the three month periods ended April 30, 2014 and 2013.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	Management does not believe that any recently issued, but not yet effective, accounting standards, if adopted, will have a material effect on the Company’s condensed financial statements.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	ASC 820, “Fair Value Measurements and Disclosures”, establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market.
	These tiers include:
	Level 1: defined as observable inputs such as quoted prices in active markets;
	Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and
	Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.
	The carrying amounts of financial assets and liabilities, such as cash, prepaid expenses, income taxes receivable, accounts payable and due to related party approximate their fair values because of the short maturity of these instruments.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Organization_and_Business_Oper1

Organization and Business Operations (Details Narrative) (USD $)	Apr. 30, 2014	Jan. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'	'
Accumulated losses	$45,785	$28,884

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details Narrative) (USD $)	3 Months Ended
	Apr. 30, 2014	Apr. 30, 2013	Jan. 31, 2014
Accounting Policies [Abstract]	'	'	'
Insured amount	$250,000	'	'
Unrecognized tax benefits	0	'	0
Advertising costs	$0	$0	'

Going_Concern_Details_Narrativ

Going Concern (Details Narrative) (USD $)	Apr. 30, 2014	Jan. 31, 2014
Going Concern	'	'
Accumulated deficit	$45,785	$28,884

Common_Stock_Details_Narrative

Common Stock (Details Narrative) (USD $)	0 Months Ended	1 Months Ended	3 Months Ended		12 Months Ended	27 Months Ended		0 Months Ended
	Oct. 22, 2012	Dec. 04, 2012	Apr. 30, 2014	Apr. 30, 2013	Jan. 31, 2014	Apr. 30, 2014	Apr. 14, 2014	Apr. 14, 2014	Apr. 14, 2014	Apr. 11, 2014	Apr. 11, 2014
								Pre-Dividend [Member]	Post-Dividend [Member]	Minimum [Member]	Maximum [Member]
Common Stock, shares authorized	'	'	750,000,000	'	750,000,000	750,000,000	29	'	'	75,000,000	750,000,000
Common stock, par value	'	'	$0.00	'	$0.00	$0.00	'	'	'	$0.00	$0.00
Common stock issued, shares	180,000,000	70,800,000	'	'	'	'	'	'	'	'	'
Common stock issued value	$6,000	$23,600	'	'	'	'	'	'	'	'	'
Changes in issued and outstanding common stock	'	'	'	'	'	'	'	8,360,000	250,800,000	'	'
Common Stock, shares issued	'	'	250,800,000	'	250,800,000	250,800,000	'	'	'	'	'
Common Stock, shares outstanding	'	'	250,800,000	'	250,800,000	250,800,000	'	'	'	'	'
Loan from shareholder	'	'	'	'	'	5,800	'	'	'	'	'
Forgiveness of repayment of loan	'	'	'	'	$5,800	$5,800	'	'	'	'	'

Related_Party_Transactions_Det

Related Party Transactions (Details Narrative) (USD $)	3 Months Ended		12 Months Ended	27 Months Ended
	Apr. 30, 2014	Apr. 30, 2013	Jan. 31, 2014	Apr. 30, 2014
Related Party Transactions [Abstract]	'	'	'	'
Proceeds from loan from related party	'	'	'	$5,800
Forgiveness of repayment of loan	'	'	5,800	5,800
Amount owed to director and principal shareholder for expense reimbursements	$3,723	'	'	$3,723

Income_Taxes_Details_Narrative

Income Taxes (Details Narrative) (USD $)	3 Months Ended		12 Months Ended		27 Months Ended
	Apr. 30, 2014	Apr. 30, 2013	Jan. 31, 2014	Jan. 31, 2013	Apr. 30, 2014
Taxable profit loss	'	'	$30,644	$1,760	'
Tax liability	'	'	'	352	'
Tax paid	'	'	'	264	'
Unrelieved tax losses remaining balance	-45,785	'	-28,884	'	-45,785
Further tax losses	($16,901)	($7,249)	($30,292)	$1,408	($45,785)
Minimum [Member]	'	'	'	'	'
Net operating loss carryforwards expiration year	'2033	'	'	'	'
Maximum [Member]	'	'	'	'	'
Net operating loss carryforwards expiration year	'2034	'	'	'	'

Subsequent_Event_Details_Narra

Subsequent Event (Details Narrative) (Subsequent Event [Member])	0 Months Ended
	Jun. 10, 2014
Subsequent Event [Member]	'
Percentage of shares acquired	100.00%
Allotment and issuance of restricted shares for exchange	150,000,000